Zydus Lifesciences Adjusts Evaluation Score Amid Strong Financial Performance and Growth Trends
Zydus Lifesciences has recently adjusted its evaluation score, reflecting a change in technical trends. The company showcases strong financial health with a consistent annual net sales growth of 10.41% and an operating profit growth of 24.54%. It has maintained a low debt-to-equity ratio and a return on equity of 19.49%.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bearish to a mildly bullish outlook. The company has demonstrated a solid financial foundation, highlighted by a consistent annual growth rate in net sales of 10.41% and an impressive operating profit growth of 24.54%. Zydus Lifesciences has maintained a low debt-to-equity ratio, indicating strong long-term fundamental strength. Additionally, the company has achieved a return on equity of 19.49%, showcasing its ability to generate significant profitability relative to shareholders' funds.
In terms of performance, Zydus Lifesciences has reported positive results for the last eight consecutive quarters, with a profit after tax of Rs 2,358.67 crore, reflecting a growth of 20.80% over the latest six months. The stock is currently trading at a fair value compared to its peers, with a price-to-book ratio of 4.1, and has shown resilience with a notable return of 173.21% over the past three years.
For those interested in further insights, you can explore more about Zydus Lifesciences and its financial trend performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
